Numerate Company
Numerate seeks to overcome major challenges in drug discovery by applying novel machine-learning algorithms, at cloud scale, to drug design.
Investors
Connections from
Founded Date:
2007-03-18
Technology:
Anti-infective Drugs
Investor Type:
info@numerate.com
Funding Status:
M&A
Total Funding:
19420487.0
Employee Number:
11-50
Headquarters:
San Bruno, California, United States
Last Funding Date:
2019-08-08
Investors Number:
5.0
Last Funding Type:
Grant
Estimated Revenue:
$1M to $10M
Industry:
Medical BioTech